Chronic underperformer. Technically on a downtrend even when the rest of the market is on the way up.
Revenue, gross profit and net profit all dropped in FY12. No dividends declared since FY 2006.
Still worth a buy? I'm not so sure.
This stock is only for speculation.
Hope this stock never goes up, the new hxnx is nothing bad.
With more SARS-related news getting more prominent, do consider Medtecs. Wars could also be around the corner.
Vested at 0.6 cents.